PROTEASE-ACTIVATED RECEPTOR (PAR)1 ALTERS BIOELECTRIC PROPERTIES OF DISTAL LUNG EPITHELIA WITHOUT COMPROMISING BARRIER FUNCTION

Author： Moraes Theo Rafii Bijan Niessen Frank Suzuki Tomoko Martin Raiza Vachon Eric Vogel Wolfgang Ruf Wolfram O'Brodovich Hugh Downey Gregory

Publisher： Informa Healthcare

ISSN： 1521-0499

Source： Experimental Lung Research, Vol.35, Iss.2, 2009-03, pp. : 136-154

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peptide-Derived Protease-Activated Receptor-1 (PAR-1) Antagonists

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 1, Iss. 1, 2003-03 ,pp. : 1-11

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Potent Peptide-Mimetic Antagonists for the Human Thrombin Receptor, Protease-Activated Receptor-1 (PAR-1)

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 1, Iss. 1, 2003-03 ,pp. : 13-36

Bentham Science Publishers

Access to resources Recommend Favorite

Expression and Cytoprotective Effect of Protease-activated Receptor-1 in Gastric Epithelial Cells

By Toyoda N. Gabazza E. C. Inoue H. Araki K. Nakashima S. Oka S. Taguchi Y. Nakamura M. Suzuki Y. Taguchi O. Imoto I. Suzuki K. Adachi Y.

Scandinavian Journal of Gastroenterology, Vol. 38, Iss. 3, 2003-01 ,pp. : 253-259

Informa Healthcare

Access to resources Recommend Favorite

Vorapaxar, a Protease-Activated Receptor-1 Antagonist, a Double –Edged Sword!

Recent Patents on Cardiovascular Drug Discovery, Vol. 9, Iss. 2, 2014-12 ,pp. : 73-77

Bentham Science Publishers

Access to resources Recommend Favorite

Protease-Activated Receptor-2 Antagonists and Agonists

Current Medicinal Chemistry - Cardiovascular & Hematological Agents, Vol. 1, Iss. 1, 2003-03 ,pp. : 73-82

Bentham Science Publishers

Access to resources Recommend Favorite